Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
暂无分享,去创建一个
P. Andersen | A. Fomsgaard | G. Gram | C. Schou | S. Tang | Ingrid Kromann | P. Bang | I. Karlsson | L. V. Andreasen